Zhang Y, Yang L, Gai C, Cheng C, Guo Z, Sun H
Front Psychiatry. 2022; 13:976428.
PMID: 36061291
PMC: 9433753.
DOI: 10.3389/fpsyt.2022.976428.
Meng X, Zheng J, Sun M, Lai H, Wang B, Yao J
PLoS One. 2022; 17(7):e0271170.
PMID: 35834596
PMC: 9282595.
DOI: 10.1371/journal.pone.0271170.
Wan L, Wei J
Neuropsychiatr Dis Treat. 2021; 17:2511-2525.
PMID: 34376980
PMC: 8349230.
DOI: 10.2147/NDT.S320680.
Morris E, Hippman C, Albert A, Slomp C, Inglis A, Carrion P
PLoS One. 2020; 15(12):e0243936.
PMID: 33315905
PMC: 7735580.
DOI: 10.1371/journal.pone.0243936.
Hsieh Y, Chou L, Lin C, Wu H, Li D, Tseng P
BMC Psychiatry. 2019; 19(1):305.
PMID: 31640634
PMC: 6805488.
DOI: 10.1186/s12888-019-2269-2.
Age Matters: an Atypical Association Between Polymorphism of MTHFR and Clinical Phenotypes in Children with Schizophrenia.
Wan L, Li Y, Zhou Y, Li R, Zheng Y
J Mol Neurosci. 2019; 69(3):485-493.
PMID: 31302825
DOI: 10.1007/s12031-019-01382-0.
Methylenetetrahydrofolate reductase and psychiatric diseases.
Wan L, Li Y, Zhang Z, Sun Z, He Y, Li R
Transl Psychiatry. 2018; 8(1):242.
PMID: 30397195
PMC: 6218441.
DOI: 10.1038/s41398-018-0276-6.
Haplotypic and Genotypic Association of Catechol--Methyltransferase rs4680 and rs4818 Polymorphisms and Treatment Resistance in Schizophrenia.
Sagud M, Tudor L, Uzun S, Nikolac Perkovic M, Zivkovic M, Konjevod M
Front Pharmacol. 2018; 9:705.
PMID: 30018555
PMC: 6037851.
DOI: 10.3389/fphar.2018.00705.
Additive effect of and genetic polymorphisms on the risk of schizophrenia.
Foroughmand A, Galehdari H, Pooryasin A, Ajam T, Kazemi-Nezhad S
Mol Biol Res Commun. 2016; 4(1):33-42.
PMID: 27843994
PMC: 5019296.
CT genotype of 5,10-methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is protector factor of major depressive disorder in the Tunisian population: a case control study.
Sayadi M, Achour O, Ezzaher A, Hellara I, Omezzine A, Douki W
Ann Gen Psychiatry. 2016; 15:18.
PMID: 27478487
PMC: 4967526.
DOI: 10.1186/s12991-016-0103-5.
Evaluation of an association between plasma total homocysteine and schizophrenia by a Mendelian randomization analysis.
Numata S, Kinoshita M, Tajima A, Nishi A, Imoto I, Ohmori T
BMC Med Genet. 2015; 16:54.
PMID: 26208850
PMC: 4557634.
DOI: 10.1186/s12881-015-0197-7.
A potential interaction between COMT and MTHFR genetic variants in Han Chinese patients with bipolar II disorder.
Wang L, Lee S, Chen S, Chang Y, Chen P, Huang S
Sci Rep. 2015; 5:8813.
PMID: 25744938
PMC: 4351536.
DOI: 10.1038/srep08813.
Female specific association between NNMT gene and schizophrenia in a Han Chinese population.
Wang G, Zhang Y, Lv Z, Sun M, Wu D, Chen X
Int J Med Sci. 2014; 11(12):1234-9.
PMID: 25317069
PMC: 4196124.
DOI: 10.7150/ijms.9426.
MTHFR gene polymorphism and age of onset of schizophrenia and bipolar disorder.
El-Hadidy M, Abdeen H, El-Aziz S, Al-Harrass M
Biomed Res Int. 2014; 2014:318483.
PMID: 25101272
PMC: 4101969.
DOI: 10.1155/2014/318483.
Methylenetetrahydrofolate reductase (MTHFR) polymorphism susceptibility to schizophrenia and bipolar disorder: an updated meta-analysis.
Hu C, Qian Z, Gong F, Lu S, Feng F, Wu Y
J Neural Transm (Vienna). 2014; 122(2):307-20.
PMID: 24938371
DOI: 10.1007/s00702-014-1261-8.
Association of MTHFR C677T polymorphism with schizophrenia and its effect on episodic memory and gray matter density in patients.
Zhang Y, Yan H, Tian L, Wang F, Lu T, Wang L
Behav Brain Res. 2013; 243:146-52.
PMID: 23318463
PMC: 3755007.
DOI: 10.1016/j.bbr.2012.12.061.
C677T Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphism in Schizophrenia and Bipolar Disorder: An Association Study in Iranian Population.
Arzaghi S, Hossein-Nezhad A, Shariat S, Ghodsipour A, Shams J, Larijani B
Iran J Psychiatry. 2012; 6(1):1-6.
PMID: 22952513
PMC: 3395937.
Meta-analysis of genetic association studies on bipolar disorder.
Seifuddin F, Mahon P, Judy J, Pirooznia M, Jancic D, Taylor J
Am J Med Genet B Neuropsychiatr Genet. 2012; 159B(5):508-18.
PMID: 22573399
PMC: 3582382.
DOI: 10.1002/ajmg.b.32057.
No association of functional polymorphisms in methlylenetetrahydrofolate reductase and the risk and minor physical anomalies of schizophrenia in Korean population.
Kim S, Song J, Joo E, Jeong S, Kim S, Lee K
J Korean Med Sci. 2011; 26(10):1356-63.
PMID: 22022190
PMC: 3192349.
DOI: 10.3346/jkms.2011.26.10.1356.
Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants.
Ellingrod V, Miller D, Taylor S, Moline J, Holman T, Kerr J
Schizophr Res. 2007; 98(1-3):47-54.
PMID: 17976958
PMC: 2271139.
DOI: 10.1016/j.schres.2007.09.030.